Ultrasound and Clinicopathological Characteristics of Papillary Thyroid Carcinoma Predict the Coexistence of TERT Promoter and BRAFV600E Mutations

Ultrasound and Clinicopathological Characteristics of Papillary Thyroid Carcinoma Predict the Coexistence of TERT Promoter and BRAFV600E Mutations

Mei Yu,1,&ast; ChengZheng Zhang,1,&ast; ZhengTong Wang,2,&ast; ShaoWen Lv,3 YiFang Sun,1 WenWen Zhao,4 Lu Li,5 QingFeng Kong,3 Kun Liu,1 Shuanglong Wang3 1Department of Ultrasound Medicine, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, 272000, People’s Repu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu M, Zhang C, Wang Z, Lv S, Sun Y, Zhao W, Li L, Kong Q, Liu K, Wang S
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-03-01
Series:	International Journal of General Medicine
Subjects:	ultrasound and clinicopathological characteristics coexistence of tert promoter and brafv600e mutations papillary thyroid carcinoma predictive model risk stratification
Online Access:	https://www.dovepress.com/ultrasound-and-clinicopathological-characteristics-of-papillary-thyroi-peer-reviewed-fulltext-article-IJGM
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anlotinib may have a therapeutic effect on papillary craniopharyngiomas without the BRAFv600e mutation
by: Yilamujiang Ainiwan, et al.
Published: (2025-03-01)

Clinicopathological features of follicular thyroid carcinoma coexisting with papillary thyroid carcinoma
by: Wang Hong-qun, et al.
Published: (2025-08-01)

Distribution of BRAFV600E mutation in cytological samples of thyroid nodules and its clinical application value
by: WANG Lei, JIN Jingjing, YU Na, XIAO Li
Published: (2025-04-01)

BRAFV600E and TERT promoter mutations and their impact on recurrent papillary thyroid carcinoma progression
by: Nguyen Thi Nhung, et al.
Published: (2025-07-01)

BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
by: Jennifer A. Silver, et al.
Published: (2021-11-01)

Prediction of BRAF and TERT status in PTCs by machine learning-based ultrasound radiomics methods: A multicenter study
by: Hui Shi, et al.
Published: (2025-06-01)

BRAFV600E‐PROTAC versus inhibitors in melanoma cells: Deep transcriptomic characterization
by: Solomon O. Alhassan, et al.
Published: (2025-03-01)

Application and recent advances in conventional biomarkers for the prognosis of papillary thyroid carcinoma
by: Muzi Li, et al.
Published: (2025-05-01)

Associations between pathological features and radioactive iodine-refractory recurrent papillary thyroid carcinoma: with mutation analysis using recurrent samples
by: Thi Nhung Nguyen, et al.
Published: (2025-05-01)

Prognostic significance of clinicopathological and ultrasonographic features in anaplastic thyroid carcinoma beyond TERT promoter mutation
by: Haejung Kim, et al.
Published: (2025-04-01)

Cutaneous metastasis of cecum cancer with MSI-high and BRAFV600E mutation: a case report
by: Kosuke Yunoki, et al.
Published: (2021-08-01)

Management of asynchronous multifocal adult glioblastoma with loss of BRAFV600E -mutant clonality: a case report
by: Hannah Haile, et al.
Published: (2025-01-01)

TREATMENT OF <em>BRAF</em><sup>V600E</sup> POSITIVE ANAPLASTIC THYROID CARCINOMA: CASE REPORT
by: P. A. Nikiforovich, et al.
Published: (2020-10-01)

SLPI as a dedifferentiation biomarker in BRAFV600E-mutant papillary thyroid cancer
by: Wei Luo, et al.
Published: (2025-08-01)

Treatment outcomes of patients with BRAFV600E-mutated metastatic colorectal cancer: a Polish retrospective cohort study
by: Jolanta Żok, et al.
Published: (2025-01-01)

Clinicopathological and molecular characteristics of papillary thyroid carcinoma in adolescent and young adult patients
by: Van Phu Thang Nguyen, et al.
Published: (2025-02-01)

A combined model integrating deep learning, radiomics, and clinical ultrasound features for predicting BRAF V600E mutation in papillary thyroid carcinoma with Hashimoto’s thyroiditis
by: Peng-Fei Zhu, et al.
Published: (2025-08-01)

Association of radiomic features with genomic signatures in thyroid cancer: a systematic review
by: Neila Luciano, et al.
Published: (2024-11-01)

Relationship between the BRAF V600E and tumor size, lymph node, and distant metastasis in papillary thyroid carcinoma
by: Edmond Rukmana Wikanta, et al.
Published: (2022-06-01)

Pleural effusion metastatic papillary thyroid carcinoma with dedifferentiation: a case report and review of the literature
by: Jialing Xu, et al.
Published: (2025-05-01)

Safety and efficacy of encorafenib–cetuximab combination in BRAFV600E-mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study
by: A. Fernández-Montes, et al.
Published: (2024-09-01)

Editorial: Papillary thyroid cancer: prognostic factors and risk assessment
by: Vincenzo Marotta, et al.
Published: (2025-03-01)

Systematic analysis of BRAFV600E melanomas reveals a role for JNK/c‐Jun pathway in adaptive resistance to drug‐induced apoptosis
by: Mohammad Fallahi‐Sichani, et al.
Published: (2015-03-01)

Current issues relating to diagnostics and treatment of papillary thyroid cancer with coexistent autoimmune thyroiditis
by: S. M. Zavhorodnyi, et al.
Published: (2020-10-01)

Can mutation abundance assess the biological behavior of BRAF V600E-positive papillary thyroid carcinoma?
by: Yeqin Ni, et al.
Published: (2025-07-01)

A methyl-to-acetyl switch in H3K27 drives metabolic reprogramming and resistance to BRAFV600E inhibition in melanoma
by: Jiang Zhou, et al.
Published: (2025-10-01)

Location based BRAF V600E mutation status and dimension patterns of sporadic thyroid nodules: a population-based study
by: Hui Tang, et al.
Published: (2025-03-01)

Stratification of papillary thyroid cancer relapse risk based on the results of molecular genetic studies
by: S. A. Lukyanov, et al.
Published: (2020-04-01)

Comprehensive transcriptomic profiling reveals molecular characteristics and biomarkers associated with risk stratification in papillary thyroid carcinoma
by: Congcong Yan, et al.
Published: (2025-03-01)

Progressive Cachexia: Tuberculosis, Cancer, or Thyrotoxicosis? Disease-Directed Therapy and Atypical Courses of Autoimmune and Malignant Thyroid Diseases in a High Specialization Era: Case-Control Study with a Critical Literature Review
by: Przemyslaw Zdziarski, et al.
Published: (2024-11-01)

Clinicopathological features and outcomes in patients with concurrent medullary and papillary thyroid carcinoma
by: Ruonan Sun, et al.
Published: (2025-08-01)

Coexistence of Hashimoto's thyroiditis and papillary thyroidal carcinoma with papillary carcinoma of thyreoglossal duct
by: Čizmić Milica, et al.
Published: (2007-01-01)

Durable response to third-line combination therapy in a metastatic colorectal cancer patient with BRAF V600E mutation: A case report
by: Qun Zhang, et al.
Published: (2025-12-01)

Mutation profile of the tall cell variant of papillary thyroid carcinoma: analysis of 5 cases using wide-panel next-generation sequencing
by: I. L. Plaksa, et al.
Published: (2021-04-01)

Integrating Deep Learning and Radiomics in Differentiating Papillary Thyroid Microcarcinoma from Papillary Thyroid Carcinoma with Ultrasound Images
by: Yu B, et al.
Published: (2025-07-01)

Phosphoglycerate kinase 1 as a potential prognostic biomarker in papillary thyroid carcinoma
by: Xiao-Qing Shi, et al.
Published: (2025-07-01)

Role of contrast-enhanced ultrasound with time-intensity curve analysis about thyroid nodule and parenchyma for differentiating BRAF V600E mutation status
by: Zhipeng Hu, et al.
Published: (2025-02-01)

A risk stratification model based on ultrasound radiologic features for cervical metastatic lymph nodes in papillary thyroid cancer
by: Hai-Long Tan, et al.
Published: (2025-03-01)

Molecular mutations as a possible factor for determining extent of thyroid surgery
by: Joshua R. Krasner, et al.
Published: (2019-10-01)

Allele frequency in thyroid cancer: mechanisms, challenges, and applications in cancer therapy
by: Jiayu Huang, et al.
Published: (2025-05-01)